Thin-Walled Needle Best for Subclavian Catheterization

This article originally appeared here.
Share this content:
Thin-Walled Needle Best for Subclavian Catheterization
Thin-Walled Needle Best for Subclavian Catheterization

MONDAY, July 18, 2016 (HealthDay News) -- A thin-walled introducer needle is recommended for right-sided infraclavicular subclavian venous catheterization, with lower catheterization-related complication rates and higher initial and overall success rates of catheterization compared with a catheter-over-needle technique, according to a study published online July 11 in Anaesthesia.

E. Kim, from the Catholic University of Daegu in South Korea, and colleagues compared the incidence of catheterization-related complications and insertion success rate for thin-walled introducer needle and catheter-over-needle techniques in patients requiring right-sided subclavian central venous catheterization. Four hundred fourteen patients were randomized to a thin-walled introducer needle technique (208 patients) or catheter-over-needle technique (206 patients).

The researchers found that the needle group had a significantly lower catheterization-related complication rate compared with the catheter group (5.8 versus 15.5 percent; P = 0.001). The groups had similar overall insertion success rates (97.1 and 92.7 percent, respectively; P = 0.046), although the needle group had a higher first-pass success rate (62.0 versus 35.4 percent; P < 0.001).

"We recommend the use of a thin-walled introducer needle technique for right-sided infraclavicular subclavian venous catheterization," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »